1. The Defendant Alants Life Insurance Co., Ltd. amounting to KRW 32,500,000 and its amount from October 7, 2015 to the Plaintiff.

1. Facts of recognition;

A. On February 9, 2007, the Plaintiff entered into an insurance contract with Defendant Alger’s Life Insurance Co., Ltd. (hereinafter “Defendant Alger’s Life Insurance Co., Ltd”) on the following terms and conditions (hereinafter “instant insurance contract”).

1. Insured: Plaintiff 2) Cancer diagnostic benefits for insurance content: 25 million won upon lapse of one year or more (30% payment of general cancer diagnostic benefits in the case of boundary species): the first time shall be 7.5 million won (in the case of boundary species, 30% payment of general cancer surgery benefits):

B. The terms and conditions of the first insurance contract of this case are as follows.

1) “Cancer” means a disease classified as malicious life in the fourth Korean Standard Disease Classification (Article 11(1)); the malicious life classification number of a fire extinguishing agency according to the above classification shall be C15 through C26 (Attached Table 4); the term “dalsity species” means a disease that is classified as an unidentified or aesthetic life in the fourth Korean Standard Disease Classification (Article 13(1)); the behavior pattern of a fire extinguishing agency according to the above classification or the identity classification number in the U.S. is D37 (Attachment 6). 2); the diagnosis and determination of crymality shall be made by a person with a professional doctor’s license in the clinical or clinical pathology; the diagnosis and determination of crymality shall be made based on organizational tests, U.S. (in the case of cancer, based on the opinion of the current blood examination, but it shall be made based on the crymological diagnosis or clinical examination, if it is not possible for crymological diagnosis or clinical examination or evidence of the defendant.

Between the Department and the following non-distributions: